I-Mab Biopharma
IMAB
#9469
Rank
โ‚ฌ50.55 M
Marketcap
0,62ย โ‚ฌ
Share price
-6.87%
Change (1 day)
-63.23%
Change (1 year)

Revenue for I-Mab Biopharma (IMAB)

Revenue in 2024 (TTM): โ‚ฌ3.25 Million

According to I-Mab Biopharma's latest financial reports the company's current revenue (TTM ) is โ‚ฌ3.27 Million. In 2023 the company made a revenue of โ‚ฌ0.5 Million an increase over the revenue in the year 2022 that were of -โ‚ฌ4.25 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for I-Mab Biopharma from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ3.25 M547.39%
2023 โ‚ฌ0.5 M-111.85%
2022-โ‚ฌ4.25 Million-314.85%
2021โ‚ฌ1.97 M-94.01%
2020 โ‚ฌ33.02 M5798.4%
2019 โ‚ฌ0.55 M-46.01%
2018 โ‚ฌ1.03 M317.83%
2017โ‚ฌ0.24 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.2 M-93.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.65 B 19,776.95%๐Ÿ‡บ๐Ÿ‡ธ USA